Axsome Therapeutics Inc (AXSM)
65.74
-3.97
(-5.70%)
USD |
NASDAQ |
Apr 18, 16:00
66.00
+0.26
(+0.40%)
Pre-Market: 08:56
Axsome Therapeutics Revenue (TTM): 270.60M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 270.60M |
September 30, 2023 | 223.44M |
Date | Value |
---|---|
June 30, 2023 | 182.49M |
March 31, 2023 | 144.61M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
144.61M
Minimum
Mar 2023
270.60M
Maximum
Dec 2023
205.29M
Average
202.97M
Median
Revenue (TTM) Benchmarks
Amgen Inc | 28.19B |
Johnson & Johnson | 89.66B |
ResMed Inc | 4.504B |
Vertex Pharmaceuticals Inc | 9.869B |
Krystal Biotech Inc | -- |